SPONSOR

Emory University

Total Trials

Recruiting

Phases

Phase 3, Phase 2, Phase 1, Phase 2, Phase 1

Conditions studied: Community Violence Stage III Prostate Cancer AJCC v8 Stage IIIA Prostate Cancer AJCC v8 Stage IIIB Prostate Cancer AJCC v8 Stage IIIC Prostate Cancer AJCC v8 Mild Cognitive Impairment Communication Disorder, Childhood Autism Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Cutaneous Squamous Cell Carcinoma of the Head and Neck

Emory University is a clinical research sponsor with 31 registered studies on ClinicalTrials.gov, of which 31 are actively recruiting participants. Research covers conditions including Community Violence, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8, Stage IIIB Prostate Cancer AJCC v8.

The trial portfolio spans Phase 3, Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Emory University

How many clinical trials has Emory University sponsored?

ClinicalMetric currently tracks 31 clinical trials sponsored by Emory University, of which 31 are actively recruiting participants. These trials cover conditions including Community Violence, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Emory University research focus on?

Emory University clinical trials span Community Violence, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8, and additional conditions. The research pipeline includes Phase 3, Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Emory University clinical trial?

To participate in a Emory University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Emory University trials with current recruitment status updated daily.

Emory University

Frequently Asked Questions — Emory University

Clinical Trials by Emory University

Youth Participatory Action Research to Prevent Community Violence Among Black Youth

Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer

Voice Technology-Based Self-Management Intervention

Evaluating Georgia Part C Implementation Outcomes

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)

REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial

Virtual Home-based Exercise Intervention (RISE) to Improve Cancer-Related Cognitive Impairment and Gut Microbiome in Adolescent and Young Adult Brain Tumor Survivors

Addressing Health Literacy With a Tailored Survivorship Care Plan

Psilocybin-Assisted Therapy

Fall Prevention Pathways

Ganglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer Treatment

An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique

Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

Disrupting Fear-based Memory Consolidation

Effect of Cognitive Empathy Training on Dementia Caregivers

Thrive With Type 1 Diabetes 2026

PTSD Screening in Pregnant Black Women

MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer

Optical Imaging Scans for the Diagnosis of Skin Cancer in Patients With Lesions

CCSH (Compassion-Centered Spiritual Health) for Teams

Neurovascular Transduction During Exercise in Chronic Kidney Disease

Trans-auricular Nerve Stimulation as an Innovative Approach to the Treatment of Pain in Pediatric Patients Suffering From Sickle Cell Disease

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)

Visual Influences on Vestibular Adaptation

Improving Maternal and Child Health Through Point-of-care STI Testing

Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas

Atovaquone Combined With Radiation in Children With Malignant Brain Tumors

Sleep Quality and the Efficacy of a Multimodal Sleep Pathway in Hospitalized Orthopedic Trauma Patients